Jagiellonian University Repository

Consolidation with 90Y ibritumomab tiuxetan radioimmunotherapy in mantle cell lymphoma patients ineligible for high dose therapy : results of the phase II multicentre Polish Lymphoma Research Group trial, after 8-year long follow-up

pcg.skipToMenu

Consolidation with 90Y ibritumomab tiuxetan radioimmunotherapy in mantle cell lymphoma patients ineligible for high dose therapy : results of the phase II multicentre Polish Lymphoma Research Group trial, after 8-year long follow-up

Bibliographic description

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)